201 related articles for article (PubMed ID: 29225340)
21. MicroRNA-146a suppresses IL-17-mediated skin inflammation and is genetically associated with psoriasis.
Srivastava A; Nikamo P; Lohcharoenkal W; Li D; Meisgen F; Xu Landén N; Ståhle M; Pivarcsi A; Sonkoly E
J Allergy Clin Immunol; 2017 Feb; 139(2):550-561. PubMed ID: 27568078
[TBL] [Abstract][Full Text] [Related]
22. Antrodia cinnamomea Extract Inhibits Th17 Cell Differentiation and Ameliorates Imiquimod-Induced Psoriasiform Skin Inflammation.
Li MH; Wu HC; Yao HJ; Lin CC; Wen SF; Pan IH
Am J Chin Med; 2015; 43(7):1401-17. PubMed ID: 26477794
[TBL] [Abstract][Full Text] [Related]
23. Critical Role of CD6highCD4+ T Cells in Driving Th1/Th17 Cell Immune Responses and Mucosal Inflammation in IBD.
Ma C; Wu W; Lin R; Ge Y; Zhang C; Sun S; Cong Y; Li X; Liu Z
J Crohns Colitis; 2019 Mar; 13(4):510-524. PubMed ID: 30395204
[TBL] [Abstract][Full Text] [Related]
24. IL-23-mediated epidermal hyperplasia is dependent on IL-6.
Lindroos J; Svensson L; Norsgaard H; Lovato P; Moller K; Hagedorn PH; Olsen GM; Labuda T
J Invest Dermatol; 2011 May; 131(5):1110-8. PubMed ID: 21289639
[TBL] [Abstract][Full Text] [Related]
25. Th17 micro-milieu regulates NLRP1-dependent caspase-5 activity in skin autoinflammation.
Zwicker S; Hattinger E; Bureik D; Batycka-Baran A; Schmidt A; Gerber PA; Rothenfusser S; Gilliet M; Ruzicka T; Wolf R
PLoS One; 2017; 12(4):e0175153. PubMed ID: 28422993
[TBL] [Abstract][Full Text] [Related]
26. Th17 cells carrying TCR recognizing epidermal autoantigen induce psoriasis-like skin inflammation.
Nishimoto S; Kotani H; Tsuruta S; Shimizu N; Ito M; Shichita T; Morita R; Takahashi H; Amagai M; Yoshimura A
J Immunol; 2013 Sep; 191(6):3065-72. PubMed ID: 23956432
[TBL] [Abstract][Full Text] [Related]
27. IL-17-Secreting γδ T Cells Are Completely Dependent upon CCR6 for Homing to Inflamed Skin.
Campbell JJ; Ebsworth K; Ertl LS; McMahon JP; Newland D; Wang Y; Liu S; Miao Z; Dang T; Zhang P; Charo IF; Singh R; Schall TJ
J Immunol; 2017 Nov; 199(9):3129-3136. PubMed ID: 28972090
[TBL] [Abstract][Full Text] [Related]
28. The tripeptide KdPT ameliorates ongoing psoriasis-like skin inflammation in murine and human skin.
Mykicki N; Klenner L; Baumann C; Auriemma M; Sternemann C; Soeberdt M; Elliott GR; Abels C; Luger TA; Loser K
Exp Dermatol; 2017 Apr; 26(4):328-334. PubMed ID: 27376341
[TBL] [Abstract][Full Text] [Related]
29. Leptin deficiency in mice counteracts imiquimod (IMQ)-induced psoriasis-like skin inflammation while leptin stimulation induces inflammation in human keratinocytes.
Stjernholm T; Ommen P; Langkilde A; Johansen C; Iversen L; Rosada C; Stenderup K
Exp Dermatol; 2017 Apr; 26(4):338-345. PubMed ID: 27488462
[TBL] [Abstract][Full Text] [Related]
30. Itolizumab, a novel anti-CD6 monoclonal antibody: a safe and efficacious biologic agent for management of psoriasis.
Dogra S; Uprety S; Suresh SH
Expert Opin Biol Ther; 2017 Mar; 17(3):395-402. PubMed ID: 28064543
[TBL] [Abstract][Full Text] [Related]
31. Anti-IL-17A and IL-23p19 antibodies but not anti-TNFα antibody induce expansion of regulatory T cells and restoration of their suppressive function in imiquimod-induced psoriasiform dermatitis.
Shimizu T; Kamata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
J Dermatol Sci; 2019 Sep; 95(3):90-98. PubMed ID: 31362906
[TBL] [Abstract][Full Text] [Related]
32. An Interleukin-25-Mediated Autoregulatory Circuit in Keratinocytes Plays a Pivotal Role in Psoriatic Skin Inflammation.
Xu M; Lu H; Lee YH; Wu Y; Liu K; Shi Y; An H; Zhang J; Wang X; Lai Y; Dong C
Immunity; 2018 Apr; 48(4):787-798.e4. PubMed ID: 29653697
[TBL] [Abstract][Full Text] [Related]
33. Isogarcinol Extracted from Garcinia mangostana L. Ameliorates Imiquimod-Induced Psoriasis-like Skin Lesions in Mice.
Chen S; Han K; Li H; Cen J; Yang Y; Wu H; Wei Q
J Agric Food Chem; 2017 Feb; 65(4):846-857. PubMed ID: 28081600
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-210 overexpression promotes psoriasis-like inflammation by inducing Th1 and Th17 cell differentiation.
Wu R; Zeng J; Yuan J; Deng X; Huang Y; Chen L; Zhang P; Feng H; Liu Z; Wang Z; Gao X; Wu H; Wang H; Su Y; Zhao M; Lu Q
J Clin Invest; 2018 Jun; 128(6):2551-2568. PubMed ID: 29757188
[TBL] [Abstract][Full Text] [Related]
35. Multi-glycoside of Tripterygium wilfordii Hook. f. ameliorates imiquimod-induced skin lesions through a STAT3-dependent mechanism involving the inhibition of Th17-mediated inflammatory responses.
Zhao J; Di T; Wang Y; Liu X; Liang D; Zhang G; Li P
Int J Mol Med; 2016 Sep; 38(3):747-57. PubMed ID: 27431437
[TBL] [Abstract][Full Text] [Related]
36. An alternative pathway of imiquimod-induced psoriasis-like skin inflammation in the absence of interleukin-17 receptor a signaling.
El Malki K; Karbach SH; Huppert J; Zayoud M; Reissig S; Schüler R; Nikolaev A; Karram K; Münzel T; Kuhlmann CR; Luhmann HJ; von Stebut E; Wörtge S; Kurschus FC; Waisman A
J Invest Dermatol; 2013 Feb; 133(2):441-51. PubMed ID: 22951726
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of IL-17-committed T cells in a murine psoriasis model by a vitamin D analogue.
Kusuba N; Kitoh A; Dainichi T; Honda T; Otsuka A; Egawa G; Nakajima S; Miyachi Y; Kabashima K
J Allergy Clin Immunol; 2018 Mar; 141(3):972-981.e10. PubMed ID: 28870465
[TBL] [Abstract][Full Text] [Related]
38. Distinct roles of IL-23 and IL-17 in the development of psoriasis-like lesions in a mouse model.
Nakajima K; Kanda T; Takaishi M; Shiga T; Miyoshi K; Nakajima H; Kamijima R; Tarutani M; Benson JM; Elloso MM; Gutshall LL; Naso MF; Iwakura Y; DiGiovanni J; Sano S
J Immunol; 2011 Apr; 186(7):4481-9. PubMed ID: 21346238
[TBL] [Abstract][Full Text] [Related]
39. Involvement of IL-17F via the induction of IL-6 in psoriasis.
Fujishima S; Watanabe H; Kawaguchi M; Suzuki T; Matsukura S; Homma T; Howell BG; Hizawa N; Mitsuya T; Huang SK; Iijima M
Arch Dermatol Res; 2010 Sep; 302(7):499-505. PubMed ID: 20148256
[TBL] [Abstract][Full Text] [Related]
40. Cutting Edge: Selective Oral ROCK2 Inhibitor Reduces Clinical Scores in Patients with Psoriasis Vulgaris and Normalizes Skin Pathology via Concurrent Regulation of IL-17 and IL-10.
Zanin-Zhorov A; Weiss JM; Trzeciak A; Chen W; Zhang J; Nyuydzefe MS; Arencibia C; Polimera S; Schueller O; Fuentes-Duculan J; Bonifacio KM; Kunjravia N; Cueto I; Soung J; Fleischmann RM; Kivitz A; Lebwohl M; Nunez M; Woodson J; Smith SL; West RF; Berger M; Krueger JG; Ryan JL; Waksal SD
J Immunol; 2017 May; 198(10):3809-3814. PubMed ID: 28389592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
